Symmetry Medical Inc. (SMA)
8.69USD
9 Feb 2010
$0.18 (+2.12%)
$8.69
--
$8.70
$8.49
158,120
230,419
$11.55
$3.90
SMA
About
Overall
| Beta: | 1.08 |
| Market Cap (Mil.): | $311.15 |
| Shares Outstanding (Mil.): | 35.81 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| SMA | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 9.47 | 4.05 | 3.76 |
| EPS (TTM): | 344.58 | -- | -- |
| ROI: | 8.27 | 2.37 | 2.30 |
| ROE: | 12.27 | 3.77 | 2.82 |
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 26
Oct 26 (Reuters) - Some small and midcap stocks on the move on Monday: VIVUS INC , $10.06, up 9 pct
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 26
Oct 26 (Reuters) - Some small and midcap stocks on the move on Monday:
HEADLINE STOCKS-Some U.S. stocks on the move on Oct. 26
(Updates to after the open, adds National Oilwell, Symmetry Medical, China Life)
UPDATE 1-Symmetry Medical cuts '09 view, shares drop
Oct 26 (Reuters) - Orthopaedic-implants maker Symmetry Medical Inc cut its 2009 outlook, citing reduced order flow due to lower-than-expected demand in both its orthopaedic and non-orthopaedic markets, sending its shares down 26 percent.
Symmetry Medical slides after outlook cut
NEW YORK (Reuters) - Symmetry Medical Inc shares dropped 7.5 percent to $8.84 in premarket trade on Monday after the company cut its full-year earnings and revenue outlook.
BEFORE THE BELL-Symmetry Medical slides after outlook cut
NEW YORK, Oct 26 (Reuters) - Symmetry Medical Inc shares dropped 7.5 percent to $8.84 in premarket trade on Monday after the company cut its full-year earnings and revenue outlook. [ID:nWNAB4222]
US-RESEARCH/ (NON-S&P500)
Pride International Tristone Cuts to market perform from top pick on valuation
US RESEARCH SUMMARY-Non-S&P 500 May 1 1355 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 May 1 1226 GMT
Following is a summary of research actions on non-S&P 500 companies reported
UPDATE2-Symmetry Medical posts Q4 profit, '09 view cheers shares
* Shares rise as much as 31 percent (Adds analyst's comments, share movement)
Competitors
| Price | Change | |
|---|---|---|
| Boston Scientific Corporation (BSX.N) | $8.23 | +0.08 |
| Becton, Dickinson and Co. (BDX.N) | $75.26 | +0.58 |
| C.R. Bard, Inc. (BCR.N) | $81.36 | +0.60 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
